Estimations des analystes de Wall Street pour Autolus Therapeutics plc (AUTL): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 11 |
| Conserver | 3 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 14 |
| Note moyenne (1-5) | 0.79 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-0.20 | ||
| 2026-08-11 | $-0.15 | $-0.21 | +28.6% |
| 2026-05-14 | $-0.27 | $-0.29 | +6.9% |
| 2026-03-27 | $-0.34 | $-0.26 | -30.8% |
| 2025-11-12 | $-0.30 | $-0.23 | -30.4% |
| 2025-08-12 | $-0.18 | $-0.24 | +25.0% |
| 2025-05-08 | $-0.26 | $-0.24 | -8.3% |
| 2025-03-20 | $-0.09 | $-0.21 | +57.1% |
Ratios de valorisation
| Prix / Valeur comptable | 6.51 |
| EV / EBITDA | -2.30 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $1.2M | $1.7M | $1.0M | $2.9M | $1.7M | $1.5M | $6.2M | $1.7M | $10.1M | $75.6M |
| Coût des Ventes | $478000 | $1.0M | $48.3M | $105.4M | $134.9M | 0 | 0 | 0 | $141.0M | $96.6M |
| Marge Brute | $734000 | $684000 | -$47.3M | -$102.5M | -$133.2M | $1.5M | $6.2M | $1.7M | -$130.9M | -$21.0M |
| R&D | $10.4M | $16.0M | $24.6M | $105.6M | $135.0M | $110.8M | $117.4M | $130.5M | $158.1M | $128.6M |
| Frais Généraux | $5.2M | $9.1M | $16.8M | $39.5M | $35.0M | $31.9M | $31.9M | $46.7M | 0 | $131.8M |
| Charges Opérationnelles | $15.6M | $25.1M | $41.5M | $145.1M | $170.0M | $141.9M | $149.1M | $181.4M | $110.5M | $260.4M |
| Résultat Opérationnel | -$14.4M | -$23.4M | -$57.5M | -$247.6M | -$303.1M | -$140.4M | -$142.9M | -$179.7M | -$241.4M | -$281.4M |
| EBITDA | -$13.9M | -$22.4M | -$50.3M | -$137.4M | -$162.6M | -$132.5M | -$132.2M | -$156.8M | -$233.1M | -$250.3M |
| Charges d'Intérêt | 0 | 0 | $12667 | 0 | 0 | $1.1M | $8.9M | $45.1M | $9.3M | $36.8M |
| Résultat Avant Impôts | -$14.3M | -$23.4M | -$36.3M | -$108.7M | -$166.3M | -$142.0M | -$148.6M | -$208.4M | -$219.1M | -$296.8M |
| Impôts | -$1.8M | -$3.7M | -$5.2M | $15.2M | -$24.2M | $58000 | $272000 | -$19000 | $1.5M | -$8.6M |
| Résultat Net | -$12.6M | -$19.7M | -$31.1M | -$123.8M | -$142.1M | -$142.1M | -$148.8M | -$208.4M | -$220.7M | -$288.2M |
| BPA | $-0.91 | $-1.43 | $-0.99 | $-2.88 | $-2.76 | $-1.97 | $-1.57 | $-1.20 | $-0.87 | $-1.08 |
| BPA Dilué | $-0.91 | $-1.43 | $-0.99 | $-2.88 | $-2.76 | $-1.97 | $-1.57 | $-1.20 | $-0.87 | $-1.08 |
| Actions en Circulation (Diluées) | $13.8M | $13.8M | $31.6M | $43.1M | $51.6M | $72.1M | $95.0M | $173.9M | $255.2M | $266.1M |
Prix
| Prix | $1.87 |
| Capitalisation | $498M |
| Bourse | NASDAQ |
| Pays | GB |
Entreprises liées: ADCT · ANNX · AURA · BNTC · LBRX · NMRA · QSI
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de AUTL: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions